This year’s journey of co-authoring multiple research papers (8), we feel proud and humbled by the collective effort and trust from our collaborators.
This effort has also been recognized when Milo Malanga PhD received the 1st Thorseinn Loftsson award for cyclodextrin research recently.
Our work — from advancing molecular understanding of cyclodextrin host–guest systems and enantioselective complexation, to proposing a clearer nomenclature for modified cyclodextrins, and exploring innovative drug delivery strategies — contributes to practical building blocks for pharmaceutical science.
Cyclodextrins and their derivatives remain versatile tools in enhancing drug solubility, stability, and delivery performance, and clearer frameworks and analytical insights help accelerate their adoption in real-world drug development.
Science is a shared effort — these studies represent many minds thinking together to address complex challenges in drug formulation and molecular design.
We are thankful to our co-authors, reviewers, and supporting institutions for making this possible.
Looking forward to what we’ll discover next!
